BeiGene Co.,Ltd Signs Up Industry Veterans for Scientific Advisory Board

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

August 20, 2103 -- BeiGene, Ltd., a Beijing pharma formed in 2010, announced a Scientific Advisory Board that includes an international list of experts with experience in oncology drugs. The Board is comprised of: Neal Rosen, MD, PhD; David Schenkein, MD; Charles Sawyers, MD; Xiaodong Wang, PhD; and Steve Young, PhD. BeiGene discovers its own cancer drug candidates and in-licenses molecules that are close to clinical stage for China development. It calls itself a proof-of-concept company. More details....

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC